George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block Admission Interim Review

1 Aug 2022 09:30

RNS Number : 4149U
Quadrise Fuels International PLC
01 August 2022
 

1 August 2022

 

Quadrise Fuels International plc

("Quadrise", or "Company")

 

Block Admission Interim Review

 

Quadrise (AIM:QFI), the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels, provides an update in relation to the Company's block admission arrangements (the "Block Admissions") in respect of new ordinary shares of 1 pence in the Company ("Ordinary Shares") which may be issued as a result of future exercises of existing warrants. The Block Admissions have been put in place to enable the Company to handle any future exercises of existing warrants in an efficient manner. 

 

Block Admission Interim Review

 

Pursuant to Rule 29 of, and Schedule Six to, the AIM Rules for Companies, the Company provides the following notification regarding its Block Admissions.

 

 

Name of the company:

 

 

Quadrise Fuels International plc

 

Name of scheme:

 

1. Warrants to subscribe for new Ordinary Shares at a price of 3.532 pence per new Ordinary Share at any time until expiry on 27 February 2022 issued by the Company in December 2019 (the "December 2019 Warrants"). The grant of the December 2019 Warrants was announced by the Company on 29 November 2019 in connection with a Morocco Representation Agreement announced on 6 March 2019.

 

2. Warrants to subscribe for new Ordinary Shares at a price of 5.78 pence per new Ordinary Share at any time until expiry on 27 September 2022 issued by the Company in September 2019 (the "September 2019 Warrants"). The grant of the September 2019 Warrants was first announced by the Company on 23 August 2019 in connection with a then announced issue of convertible securities by the Company. 

 

3.  Warrants to subscribe for new Ordinary Shares at a price of 7.48 pence per new Ordinary Share at any time until 6 September 2022 issued by the Company in September 2019 (the "September 2019 - Open Offer Warrants"). The grant of the September 2019 - Open Offer Warrants was announced by the Company on 30 September 2019 in connection with an open offer to existing Quadrise shareholders first announced on 9 September 2019. 

 

4. Warrants to subscribe for new Ordinary Shares at a price of 7.48 pence per new Ordinary Share at any time until expiry on 6 September 2022 issued by the Company in September 2019 (the "September 2019 - Subscription Warrants"). The grant of the September 2019 - Subscription Warrants was announced by the Company on 9 September 2019 in connection with a then announced subscription for new ordinary shares in the Company.

 

 

 

 

Period of return:

From:

1 February 2022

To:

31 July 2022

Number of unallotted securities not issued under the scheme(s) at the start of the period:

1:

2:

3:

4:

Total:

3,000,000

4,900,000

23,273,210

9,050,506

40,223,716

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1:

2:

3:

4:

Total:

0

0

0

0

0

Less:  Number of securities issued/allotted under scheme(s) during period:

1:

2:

3:

4:

Total:

0

0

0

0

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

 

1:

 

2:

 

3:

 

4:

 

Total:

 

3,000,000 warrants expired on 27 February 2022

 

4,900,000

 

23,273,210

 

9,050,506

 

37,223,716

 

Number and class of securities originally admitted and the date of admission:

 

1:

 

2:

 

3:

 

4:

 

Total:

 

 

3,000,000 - 5 August 2021

 

4,900,000 - 5 August 2021

 

23,277,519 - 5 August 2021

 

9,050,506 - 5 August 2021

 

40,228,025

Name of contact:

Ian Farrelly, Company Secretary

Telephone number of contact:

+44 (0) 20 7031 7321

 

 

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc

Jason Miles, Chief Executive Officer

+44 (0)20 7031 7321

David Scott, Head of Finance

Nominated Adviser

Cenkos Securities plc

Ben Jeynes

+44 (0)20 7397 8900

Katy Birkin

 

Broker

Shore Capital Stockbrokers Limited

Toby Gibbs

+44 (0)20 7408 4090

Fiona Conroy

Public & Investor Relations

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

 

 

 

 

Notes to Editors

QFI is the supplier of MSAR® and bioMSARTM emulsion technology and fuels, low-cost alternatives to heavy fuel oil (one of the world's largest fuel markets, comprising over 340 million tons per annum) in the global power generation, shipping, industrial and refining industries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRUARWRUOUWRRR
Date   Source Headline
2nd Feb 20217:00 amRNSUpdate re Morocco and Greenfield Energy Projects
1st Feb 20217:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 20217:00 amRNSIssue of Equity
21st Jan 20217:00 amRNSJoint Development Agreement - MSC Shipmanagement
6th Jan 20217:00 amRNSIssue of Equity
4th Jan 20217:00 amRNSChange of Registered Office
18th Dec 202011:46 amRNSUpdate re Greenfield MSAR Trial
18th Dec 20207:00 amRNSbioMSAR Testing Update & Collaboration Agreement
15th Dec 20207:00 amRNSLaunch of bioMSAR
3rd Dec 20207:00 amRNSPublication of Americas White Paper
27th Nov 202012:13 pmRNSResult of AGM
27th Nov 20207:00 amRNSAGM Statement
24th Nov 20208:00 amEQSQuadrise Fuels International (QFI): The clean solution to a global problem
2nd Nov 20205:23 pmRNSPosting of Annual Report and Notice of AGM
26th Oct 20207:00 amRNSMorocco Update
5th Oct 20207:00 amRNSFinal Results, Investor Presentation & AGM Notice
7th Sep 20205:56 pmRNSIssue of Equity
7th Sep 20207:00 amRNSNotice of Results, Update and Investor Event
24th Aug 20207:00 amRNSIssue of Share Options
20th Aug 20207:00 amRNSIssue of Equity
18th Aug 20207:22 amRNSGreenfield MSAR Commercial Trial Agreement
17th Aug 20207:00 amRNSPublication of White Paper
17th Jul 20203:59 pmRNSInvestor Presentation
30th Jun 20209:18 amRNSHolding(s) in Company
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSIssue of Equity
18th Jun 20207:00 amRNSStatement re MSAR Licensing and Upstream Trial
17th Jun 20201:47 pmRNSStatement re MSAR Licensing
2nd Jun 20207:00 amRNSInvestor Presentation
1st May 20207:00 amRNSFurther Statement re Covid-19 and Update
16th Apr 20202:21 pmRNSIssue of Equity
15th Apr 20207:00 amRNSDirectorate Change
30th Mar 20204:13 pmRNSNew Website
30th Mar 202011:02 amRNSHalf-year Report - Replacement
30th Mar 20207:00 amRNSHalf-year Report
24th Mar 202010:13 amRNSIssue of Equity
16th Mar 20207:00 amRNSStatement re Covid-19 and Morocco Pilot Trial
5th Mar 20209:10 amRNSUpdate on Morocco Pilot Trial
17th Feb 20207:00 amRNSNotice of Interim Results and Business Update
30th Jan 20207:00 amRNSAppointment of New Auditors
15th Jan 20207:00 amRNSDirectorate Changes
16th Dec 20198:38 amRNSDirectorate Change
29th Nov 20194:42 pmRNSResult of AGM
29th Nov 20197:05 amRNSIssue of Warrants
29th Nov 20197:00 amRNSAGM Update
29th Nov 20197:00 amRNSMaterial Transfer & Cooperation Agreement
6th Nov 20195:03 pmRNSPosting of Annual Report and Notice of AGM
10th Oct 20195:42 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSNew three-year Exclusive Agreement with Nouryon

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.